By carefully analyzing immune parameters alongside clinical variables such as histological grade and TNM stage, we aim to uncover the complex connections between TLR-9 expression, disease severity, and the potential impact of EBV infection. This evidence concerns the gene TLR9 and Epstein-Barr virus infection.